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Abstract
Background: Gaucher disease type I, the non-neuropathic type, usually presents in adulthood
with hepatosplenomegaly. We report here an adult with type I Gaucher disease presented with
unusual and severe clinical manifestations.
Case presentation: Hepatosplenomegaly, bone crisis and fractures occurred at early childhood,
and splenectomy was performed at the age of 5. Exophthalmos with increase in retrobulbar space
was noted when the patient was 30. Cerezyme infusion started at the age of 32; but unfortunately,
pulmonary arteriovenous malformation with dyspnea and hypoxemia was found two years later.
Gene analysis revealed V375L/L444P mutations in the β -glucocerebrosidase gene.
Conclusion: Although both eye and lung diseases have been associated with Gaucher disease, this
is the first reported demonstration of exophthalmos and pulmonary arteriovenous malformation
in the same patient. This case may therefore present an extremely severe and unusual form of type
I Gaucher disease.
Backgound
Gaucher disease is a lysosomal storage disorder caused by
a recessively inherited deficiency of glucocerebrosidase
activity, which causes an accumulation of sphingolipid
glucosylceramide in cells of the reticulo-endothelial sys-
tems [1]. The "Gaucher cells" can be found in the spleen,
liver, bone, and central nerve system in affected individu-
als, causing hepatosplenomegaly, anemia, thrombocyto-
penia and skeletal diseases [1]. Three clinical forms of the
disease have been described, based on the absence (type
I) or the presence (types II and III) of neurological
involvement in addition to the visceral findings [1].
Pulmonary involvement, with Gaucher cell infiltration of
the alveolar or interstitial spaces [2], may be more com-
mon than previously thought, but clinically significant
lung disease is still rare [3]. Pulmonary arteriovenous
shunting has been implicated as the etiology of hypox-
emia in patients with long-standing liver disease related to
Gaucher disease [4,5]. Pulmonary arteriovenous malfor-
mation (AVM) in Gaucher disease, however, has not been
reported in the English literature. Ocular manifestations
of type I Gaucher disease include infiltration of the retina,
conjunctiva and uvea with visual loss [6-8]. However,
exophthalmos related to Gaucher disease has also not
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been described. Here we report an adult with Gaucher dis-
ease complicated with these two unusual manifestations,
exophthalmos and pulmonary AVM.
Case presentation
This 34-year-old woman was a case of Gaucher disease
type I with initial presentation of hepatosplenomegaly
and severe bone diseases including fractures of the lower
extremities and bone crisis at childhood. She was the sec-
ond of a pair of twins. Her twin sister and another younger
sister are both affected. There is no consanguinity in the
family. She underwent splenectomy at age 5 years due to
persistent thrombocytopenia, but the diagnosis of Gau-
cher disease was established only after a bone marrow
examination at age 11 years. Her leukocytes β -glucocere-
brosidase activity checked at age 26 years was 1.56 nmol/
mg/h (normal: >28.42 nmol/mg/h). At that time, she had
severe bone deformities, hepatomegaly, anemia, clubbing
fingers and toes, but pink lips. There was no audible heart
murmur, and her breathing sound was clear. Her liver size
was measured 5 cm below subcostal margin at right mid-
clavicular line, and neither spider angiomata nor superfi-
cial vein engorgement was found. Hemogram revealed a
platelet count of 103 × 109/L and hemoglobin level of 9.6
mg/dL. DNA analysis of this patient and her two affected
siblings all revealed a V375L/L444P genotype of the β -glu-
cocerebrosidase gene.
The patient complained of bilateral orbital pain with
gradual protrusion of eyes since 30 years old. Thyroid
function tests, including T3, T4, thyroid-stimulating hor-
mone and free T4, showed normal results. Ophthalmo-
logic examinations failed to reveal any specific findings
related to the exophthalmos. Magnetic resonance imaging
(MRI) of the eyes revealed increases in retrobulbar space
with fat-like density and mild hypertrophy of extra-ocular
muscles (Fig. 1A). She received enzyme replacement ther-
apy (ERT) with imiglucerase (Cerezyme) at a dose of 60
U/kg every two weeks since 32 years old. Her exophthal-
mos progressed slightly during the first year of ERT, and
then started to regress. Exposure conjunctivitis still both-
ered her currently.
The patient suffered from intermittent dyspnea at age 34
years. She became cyanotic and had an oxygen saturation
of 85% as measured by pulse oximeter. Arterial blood gas
analysis revealed a pH of 7.41, carbon dioxide tension of
27.9 mmHg, and oxygen tension of 61.2 mmHg in room
air. A grade III/VI bruit was audible over the right lower
chest, and a chest x-ray revealed prominent pulmonary
conus and increased infiltration over the right lower lung
field (Fig. 1B). A high-resolution computed tomography
(HRCT) of the chest suspected an AVM with engorged
right inferior pulmonary artery and its draining veins (Fig.
1C); but no focal lesions were found in the lung paren-
chyma. Right pulmonary artery angiogram showed several
dilated and tortuous vessels from the right pulmonary
artery, which directly connected to vessels draining into
the right pulmonary vein over the right lower lobe of the
lung (Fig. 1D). Early appearance of contrast medium in
the right pulmonary vein indicated the presence of pul-
monary arteriovenous malformation. The patient's pul-
monary artery pressures were 48/19 mmHg (mean, 33
mmHg). Embolization was achieved with 6 coils, and
resulted in a rise of oxygen saturation to 96%, although
residual shunt was still present. Unfortunately, two
months later, dyspnea and cyanosis recurred, and her oxy-
gen saturation dropped to 85% in room air. A pulmonary
function test at that time revealed moderately severe
restrictive lung disease.
Discussion
This 34-year-old patient presented symptoms and signs of
exophthalmos and pulmonary AVM, which are unusual
for Gaucher disease. She had normal mentality with no
neurological symptoms such as ophthalmoplegia, there-
fore the disease could be classified as type I. However, she
had severe thrombocytopenia requiring splenectomy and
had had repeated fracture requiring prolonged immobili-
zation. In a recent report from the Gaucher Registry, frac-
ture was present in only 15% of all patients [9]. The
patient's twin sister received splenectomy at young age
and has bone disease similar to hers. Therefore, these sis-
ters have an illness toward the severe end of the type I
Gaucher disease.
Ocular manifestations in Gaucher disease are very rare,
and the tissues reported to be involved are retina, con-
junctive, and uvea [6-8]. In the MRI study, the increased
retrobulbar spaces are filled with tissues with fat density,
suggesting that the exophthalmos is caused by Gaucher
cell infiltration. The clinical course also supports this
hypothesis, since the patient's eyes started to retract after
ERT.
Gaucher cells can infiltrate the alveolar spaces or the inter-
lobular and intralobular septa, leading to air space and
interstitial disease [2]. Gaucher cells can also plug in the
pulmonary capillary vessels and cause pulmonary hyper-
tension [10]. However, the chest x-ray and HRCT of the
index patient revealed normal lung parenchyma, not sug-
gesting direct alveolar or interstitial infiltration of Gau-
cher cells. It is also known that Gaucher disease can cause
hepatic dysfunction which may induce abnormal dilata-
tion of the intrapulmonary capillaries or the so-called
hepatopulmonary syndrome [4,5]. It is possible that pul-
monary AVM was the consequence of an abnormal pro-
gression of the hepatopulmonary syndrome, however,
there was no overt evidence of severe hepatic dysfunction
in the patient.BMC Medical Genetics 2005, 6:25 http://www.biomedcentral.com/1471-2350/6/25
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ERT has had a great impact on the outcome of Gaucher
disease [11]. On the other hand, the effect of ERT on pul-
monary hypertension remains to be established [12-15].
The patient had mild pulmonary hypertension. The pul-
monary hypertension might not be related to AVM, since
the latter condition usually causes low pulmonary artery
pressure [16]. It has been reported that pulmonary hyper-
tension may be triggered or aggravated by ERT [17]. It is
possible that the pulmonary AVM may have existed but
only caused symptoms when ERT changed intrapulmo-
nary hemodynamics after clearance of Gaucher cells.
Through a registry of 1698 patients reported in 2000, the
allele frequency of N370S was 53%, and that of L444P
Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation Figure 1
Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation. (A) MRI of the head shows increases 
in retrobulbar space and hypertrophy of extra-ocular muscles. (B) Chest X ray reveals prominent pulmonary conus and 
increased infiltration over right lower lung field. (C) High-resolution computed tomography of chest reveals engorged right 
inferior pulmonary artery and its draining veins. (D) Pulmonary angiogram demonstrates right pulmonary arteriovenous 
malformation.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Genetics 2005, 6:25 http://www.biomedcentral.com/1471-2350/6/25
Page 4 of 4
(page number not for citation purposes)
was 18% [9]. The L444P mutation is more common in
Asians [19,20], and has been detected in Taiwanese
patients with both type I and II Gaucher disease [20,21].
The prevalence of L444P and the absence of the N370S
mutation may explain the more severe phenotype in Gau-
cher disease in Asians. The V375L mutation has been clas-
sified as a mild mutation [22], which might explain the
V375L/L444P genotype in type I Gaucher disease. How-
ever, although the twin sister of the indexed person had
bone disease of similar severity, she didn't have eye or
lung problem. One the contrary, their younger sister has
less skeletal involvemen, but had dyspnea and cyanosis,
which responded to ERT. There surely are non-allelic or
epigenetic factors influencing the phenotypes.
Conclusion
Although both eye and lung diseases have been associated
with Gaucher disease, this is the first reported demonstra-
tion of exophthalmos and pulmonary AVM in the same
patient. This case may therefore present an extremely
severe and unusual form of type I Gaucher disease. Differ-
ent responses of these lesions to ERT would probably be
attributed to different pathogenesis and natural course in
the organ involvement in Gaucher disease.
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